View in EDS

Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy.

Saved in:
Bibliographic Details
Title: Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy.
Authors: Cox, Timothy M.1, Drelichman, Guillermo2, Balwani, Manisha3, Burrow, Thomas Andrew4, Lukina, Elena5, Rosenbloom, Barry6, Gaemers, Sebastiaan J.M.7, Angell, Jennifer7, Judith Peterschmitt, M.7
Source: Molecular Genetics & Metabolism. Feb2016, Vol. 117 Issue 2, pS37-S37. 1p.
Database: Academic Search Ultimate
Description
ISSN:10967192
DOI:10.1016/j.ymgme.2015.12.229